Research finds alternating estrogen and anti-estrogen therapies effective in treating metastatic breast cancer

by Dartmouth HealthCredit: Unsplash/CC0 Public DomainAdvanced or metastatic estrogen receptor-positive (ER+) breast cancer is commonly treated with drugs that block the estrogen receptor. However

Updated on: February 24,2024

Research finds alternating estrogen and anti-estrogen therapies effective in treating metastatic breast cancer

by Dartmouth HealthCredit: Unsplash/CC0 Public DomainAdvanced or metastatic estrogen receptor-positive (ER+) breast cancer is commonly treated with drugs that block the estrogen receptor. However

Updated on:February 24,2024

Research is uncovering new ways to treat an aggressive brain cancer

by Anthony King,Horizon: The EU Research & Innovation MagazineCredit: AI-generated imageBrain surgeons need steady hands as well as cool heads. Now they're getting a helping hand from re

Updated on: February 03,2024

Research is uncovering new ways to treat an aggressive brain cancer

by Anthony King,Horizon: The EU Research & Innovation MagazineCredit: AI-generated imageBrain surgeons need steady hands as well as cool heads. Now they're getting a helping hand from re

Updated on:February 03,2024

Re-engineering cancerous tumors to self-destruct and kill drug-resistant cells

byPennsylvania State UniversityCredit: Unsplash/CC0 Public DomainTreating cancer can sometimes feel like a game of Whac-A-Mole. The disease can become resistant to treatment, and clinicians neve

Updated on: July 05,2024

Re-engineering cancerous tumors to self-destruct and kill drug-resistant cells

byPennsylvania State UniversityCredit: Unsplash/CC0 Public DomainTreating cancer can sometimes feel like a game of Whac-A-Mole. The disease can become resistant to treatment, and clinicians neve

Updated on:July 05,2024

Clinical trial finds new drug significantly extends lives of breast cancer patients

byLudwig Maximilian University of MunichKaplan–Meier analysis of key efficacy endpoints in patients with baseline BMs. Credit:Nature Medicine(2024). DOI: 10.1038/s41591-024-03261-7Pa

Updated on: October 21,2024

Clinical trial finds new drug significantly extends lives of breast cancer patients

byLudwig Maximilian University of MunichKaplan–Meier analysis of key efficacy endpoints in patients with baseline BMs. Credit:Nature Medicine(2024). DOI: 10.1038/s41591-024-03261-7Pa

Updated on:October 21,2024

New CAR T-cell therapy research shows potential in solid tumors

by Peter MacCallum Cancer CenterCredit: Peter MacCallum Cancer CenterPeter Mac researchers have developed a new approach to chimeric antigen receptor (CAR) T-cell therapy which has proven effective in

Updated on: January 11,2024

New CAR T-cell therapy research shows potential in solid tumors

by Peter MacCallum Cancer CenterCredit: Peter MacCallum Cancer CenterPeter Mac researchers have developed a new approach to chimeric antigen receptor (CAR) T-cell therapy which has proven effective in

Updated on:January 11,2024

Cell division, DNA repair and cancer progression closely tied to CDK9 dysfunction

by Sbarro Health Research Organization (SHRO)CDK9 isoforms regulate DNA damage response.AWestern blot analysis of CDK9 in HeLa cells transfected with siRNA CDK9 (siCDK9) or control (siCTR)

Updated on: March 20,2024

Cell division, DNA repair and cancer progression closely tied to CDK9 dysfunction

by Sbarro Health Research Organization (SHRO)CDK9 isoforms regulate DNA damage response.AWestern blot analysis of CDK9 in HeLa cells transfected with siRNA CDK9 (siCDK9) or control (siCTR)

Updated on:March 20,2024

Prostate cancer diagnosis later for Kiwi men

by Anna Kellett,University of AucklandDr Nishi Karunasinghe. Credit: University of AucklandNew Zealand men are being diagnosed with prostate cancer later in life at a higher prostate-specific an

Updated on: March 01,2024

Prostate cancer diagnosis later for Kiwi men

by Anna Kellett,University of AucklandDr Nishi Karunasinghe. Credit: University of AucklandNew Zealand men are being diagnosed with prostate cancer later in life at a higher prostate-specific an

Updated on:March 01,2024

Study finds females have lower salivary flow than males before and after radiation therapy for head, neck cancer

byUniversity of ConnecticutCredit: Unsplash/CC0 Public DomainReduced salivary flow, or hyposalivation, can cause an increased risk for tooth decay and other mouth conditions. Measuring salivary

Updated on: September 07,2024

Study finds females have lower salivary flow than males before and after radiation therapy for head, neck cancer

byUniversity of ConnecticutCredit: Unsplash/CC0 Public DomainReduced salivary flow, or hyposalivation, can cause an increased risk for tooth decay and other mouth conditions. Measuring salivary

Updated on:September 07,2024

Cancer-predisposition variants associated with adverse outcomes in rhabdomyosarcoma

by Molly Chiu,Baylor College of MedicineKaplan-Meier Survival Outcomes of Cancer-Predisposition Variant (CPV) Status on Rhabdomyosarcoma (RMS). Credit:JAMA Network Open(2024). DOI: 1

Updated on: March 30,2024

Cancer-predisposition variants associated with adverse outcomes in rhabdomyosarcoma

by Molly Chiu,Baylor College of MedicineKaplan-Meier Survival Outcomes of Cancer-Predisposition Variant (CPV) Status on Rhabdomyosarcoma (RMS). Credit:JAMA Network Open(2024). DOI: 1

Updated on:March 30,2024

Drug-pricing program improves prostate cancer treatment adherence, finds study

by Nicole Fawcett,University of MichiganCredit: Unsplash/CC0 Public DomainProstate cancer patients receiving care at hospitals that are part of a special drug-pricing program were more likely to

Updated on: March 30,2024

Drug-pricing program improves prostate cancer treatment adherence, finds study

by Nicole Fawcett,University of MichiganCredit: Unsplash/CC0 Public DomainProstate cancer patients receiving care at hospitals that are part of a special drug-pricing program were more likely to

Updated on:March 30,2024

Treating a rare genetic disorder that causes colon cancer in children

by Laurie Fickman,University of HoustonUniversity of Houston pharmaceutical scientist Ming Hu is developing a drug that will recycle and stay inside the area it is targeting. Credit: University

Updated on: April 09,2024

Treating a rare genetic disorder that causes colon cancer in children

by Laurie Fickman,University of HoustonUniversity of Houston pharmaceutical scientist Ming Hu is developing a drug that will recycle and stay inside the area it is targeting. Credit: University

Updated on:April 09,2024

Changes in RECIST tumor measures correlate linearly with survival in patients treated with checkpoint inhibitors

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainThe Response Evaluation Criteria In Solid Tumors (RECIST), used in many clinical trials to evaluate changes in tumor burden over time, c

Updated on: January 28,2024

Changes in RECIST tumor measures correlate linearly with survival in patients treated with checkpoint inhibitors

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainThe Response Evaluation Criteria In Solid Tumors (RECIST), used in many clinical trials to evaluate changes in tumor burden over time, c

Updated on:January 28,2024